Regulatory snapshots, including global drug submissions and approvals, and other regulatory decisions and designations: Agios, Artiva, Atai, Beckley, Celltrion, Chiesi, Disc, Insmed, Kiniksa, Novartis, Protalix, Regeneron, Revolution, Roche, Sanofi, Sichuan Kelun.